Evidence map›Paper›PMID 41191197›Full record

ArticleInsights into imaging2025

Transjugular intrahepatic portosystemic shunt with ePTFE-covered stentgrafts: incidence and predictors of shunt dysfunction.

Michael B Pitton, Lukas Müller, Fabian Stoehr, Arndt Weinmann, Christian Labenz, Jens Mittler, Roman Kloeckner, Christoph Düber, Gerd Otto

Abstract read
In one paragraph

Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael B PittonDepartment of Díagnostic and Interventional Radiology, University Medical Center Mainz, Mainz, Germany. Michael.pitton@unimedizin-mainz.de.ORCID http://orcid.org/0000-0002-5572-7763
Lukas MüllerDepartment of Díagnostic and Interventional Radiology, University Medical Center Mainz, Mainz, Germany.
Fabian StoehrDepartment of Díagnostic and Interventional Radiology, University Medical Center Mainz, Mainz, Germany.
Arndt WeinmannDepartment of I. Medicine, University Medical Center Mainz, Mainz, Germany.
Christian LabenzDepartment of I. Medicine, University Medical Center Mainz, Mainz, Germany.
Jens MittlerDepartment of General, Visceral and Transplant Surgery, University Medical Center Mainz, Mainz, Germany.
Roman KloecknerInstitute of Interventional Radiology, University Hospital Schleswig-Holstein, Luebeck, Germany.
Christoph DüberDepartment of Díagnostic and Interventional Radiology, University Medical Center Mainz, Mainz, Germany.
Gerd OttoHepatobiliäry and Transplant Surgery, University Medical Center Mainz, Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo analyze revision rates after transjugular intrahepatic portosystemic shunt (TIPS) using expanded polytetrafluoroethylene-covered stentgrafts and to identify predictors of shunt revisions. MATERIALS AND

methodsThis single-center retrospective study included 514 consecutive patients (mean age 56.9 ± 12.7 years; 194 females) with TIPS placement between 2003 and 2021. Follow-up included clinical assessment, laboratory testing, ultrasound, and computed tomography. Reinterventions were categorized by type and technique. Univariable and multivariable Cox regression analyses were performed to identify predictors of shunt dilation and reduction.

resultsA total of 149 patients (28.9%) required TIPS revision: 95 (18.5%) shunt dilation, 42 (8.2%) shunt reduction, and 12 (2.3%) others. Median time to first revision was 2.8 months (3.2 months for dilation, 1.9 months for reduction). Indications for first shunt dilation were persistent or recurrent refractory ascites (n = 61), recurrent variceal bleeding (n = 7), and asymptomatic stenosis or occlusion of the TIPS tract (n = 27). Indications for shunt reduction were hepatic encephalopathy refractory to conservative measures (n = 39) and acute liver failure following TIPS (n = 3). Forty-seven patients (9.1%) underwent two or more reinterventions. Multivariable Cox analysis identified immediate post-TIPS portosystemic pressure gradients > 8 mmHg, prior hepatic encephalopathy, and hepatorenal syndrome prior to TIPS as predictors of mandatory shunt dilation. In contrast, age ≥ 65 years, female gender, serum sodium levels, and a pre-TIPS hepatic hydrothorax were predictive of shunt reduction during revision.

conclusionAround one in three patients requires shunt revision. Predictive factors for revision varied by intervention type: shunt dilation was linked to disease severity and portal pressure, whereas reduction was more closely related to the patient's age and gender. CRITICAL RELEVANCE STATEMENT: Patients who undergo TIPS require structured, long-term follow-up to identify clinical situations that may necessitate shunt adaptation or other secondary interventions. KEY POINTS: Shunt revision after TIPS occurs in one-third of patients, with prognostic significance. Several independent prognostic factors for both shunt dilation and reduction were identified. Structured long-term follow-up is crucial to identify patients needing shunt revision.

Indexed as

RevisionShunt dysfunctionStentTransjugular intrahepatic porto-systemic shunt

Identifiers

PMID41191197
PMCPMC12589687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.